Oriental AromaticsQ1 FY25

Oriental Aromatics Q1 FY25 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹445.45P/E: 144.6Market Cap: ₹1.5K CrSector: Chemicals & Petrochemicals

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3
  • Expected peak revenue of around ₹1200 crore post full capacity utilization of new plants (next few quarters).
  • New hydrogenation facility (multi-product) aimed at 700 tons annual capacity, expected to reach 70-80% utilization within 4-5 quarters.
  • Mahad single product plant phased for 250 metric tons with a stabilization timeline of 2-3 quarters post-launch.
  • Anticipated top line growth from new capacities starting contribution from Q3 FY 2024-25 (Baroda) and second half FY 2024-25 (Mahad).
  • Continuous product approvals and phased growth expected; timeline for products moving from marginal to major supplier status is 2-3.5 years.
  • India and "China Plus One" strategy considered positive drivers for growth.
  • Management cautiously optimistic about volume and revenue growth but refrains from exact percentage guidance currently due to approvals and pricing finalization.

See what Oriental Aromatics management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes
- The company has already taken term loans for ongoing projects: Downfield project has only Rs. 20 crore outstanding, and Mahad project’s highest debt would be Rs. 70 crore. - Peak debt for the current financial year is expected at Rs. 200 crore for the parent company and Rs. 80 crore for the subsidiary, totaling Rs. 280 crore at the group level. - Around Rs. 85 crore of the debt is long-term (term loans), and the rest is working capital debt, supported by inventories. - The management states they are conservative with debt and have no indication of raising additional equity or significantly increasing debt beyond planned levels. - Future CAPEX beyond current projects may happen but has not been detailed; earlier planned CAPEX has been implemented. - They aim to further reduce debt over time and maintain healthy debt ratios. There are no announcements of new fundraising through debt or equity at present.

See what Oriental Aromatics management said on order book — free account, 30 seconds.

Capex plans

Yes
  • The company has completed major CAPEX projects, including the commissioning of a Brownfield hydrogenation plant at Vadodara (commissioned July 2020) and a greenfield project in Mahad, which is in advanced commissioning and expected to contribute from the second half of FY 2024-2025.
  • The hydrogenation facility is multi-product, targeting 6-7 products with ~700 tons annual capacity, expected to reach 70-80% utilization within 4-5 quarters.
  • Mahad plant is initially a single product plant with ~250 metric tons capacity, aiming for full stabilization 2-3 quarters after going live.
  • Incremental depreciation from new facilities expected to be Rs. 8-10 crores annually.
  • Peak group-level debt expected at Rs. 280 crores for ongoing expansions.
  • Future CAPEX beyond these projects is possible but currently unspecified, with a cautious and conservative approach to funding and debt management.
  • The company is optimistic about capturing growth opportunities driven by new capacities and "China Plus One" customer shifts.

Track Oriental Aromatics — get its next earnings analysis in your feed

How does Oriental Aromatics rank vs peers in Chemicals & Petrochemicals?

Pro feature
ThisOriental Aromatics
Rev 3Mar 3

How does Oriental Aromatics rank in Chemicals & Petrochemicals?

Compare Oriental Aromatics against every Chemicals & Petrochemicals company (Q1 FY25) on revenue, margins and earnings-call signals.

View Chemicals & Petrochemicals leaderboard →

Others in Chemicals & Petrochemicals this season

  • Seya Industries (Q2 FY27)

    Revenue from Operations (Net) for the quarter ended September 30, 2026: ₹0 lakhs (no sales reported). Key results statement takeaways from Seya Industries Ltd's

  • DCM Shriram Fine Chemicals (Q2 FY27)

    9,622.39 lakhs for the quarter ended September 30, 2025, indicating a year-on-year decrease of approximately 7.8%. Key results statement takeaways from DCM Shri

  • Dhariwalcorp (Q2 FY27)

    For the half year ended September 30, 2026, consolidated revenue from operations is ₹23,640.36 lakhs, up from ₹17,767.97 lakhs in the previous comparable…

  • Agastya Energy (Q2 FY27)

    For the quarter ended 30th September 2026, the consolidated revenue from operations was ₹625.15 lakhs, down from ₹4410.2 lakhs in the same quarter last year…

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →